Abstract |
Abnormal intracellular Ca(2+) handling by the sarcoplasmic reticulum (SR) is a critical factor in the development of heart failure (HF). Not only decreased Ca(2+) uptake, but also uncoordinated Ca(2+) release plays a significant role in contractile and relaxation dysfunction. Spontaneous Ca(2+) release through ryanodine receptor (RyR) 2, a huge tetrameric protein, during diastole leads to a decrease in the SR Ca(2+) content, and also triggers delayed after depolarization that is a substrate for lethal arrhythmia. Several disease-linked mutations of RyR have been reported in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) or arrhythmogenic right ventricular cardiomyopathy type 2 (ARVC2). The unique distribution of these mutation sites has lead to the concept that an interaction among the putative regulatory domains within RyR may play a key role in regulating channel opening, and that there seems to be a common abnormality in the channel disorder of HF and CPVT/ARVC2. Recent knowledge gained from pathological conditions may lead to the development of a new therapeutic strategy for the treatment of HF or cardiac arrhythmia.
|
Authors | Masafumi Yano |
Journal | Circulation journal : official journal of the Japanese Circulation Society
(Circ J)
Vol. 72
Issue 4
Pg. 509-14
(Apr 2008)
ISSN: 1346-9843 [Print] Japan |
PMID | 18362417
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Ryanodine Receptor Calcium Release Channel
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
Topics |
- Animals
- Arrhythmias, Cardiac
(genetics, physiopathology, therapy)
- Calcium Signaling
- Calcium-Calmodulin-Dependent Protein Kinase Type 2
(physiology)
- Heart Failure
(genetics, physiopathology, therapy)
- Humans
- Ion Channel Gating
- Models, Cardiovascular
- Models, Molecular
- Mutation
- Protein Interaction Domains and Motifs
- Ryanodine Receptor Calcium Release Channel
(chemistry, genetics, physiology)
|